 NEW YORK, NY, March 17, 2021 GLOBE NEWSWIRE -- Enzo Biochem, Inc. NYSE:ENZ, a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Markets Life Sciences MedTech Investor Forum, Tuesday March 23rd at 10:45am ET. The format will be a fireside chat discussion hosted by KeyBancs Research Analyst Paul Knight. 